Onward Medical N.V. (ONWD) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.366x

Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.366x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.25 Million ≈ $-23.68 Million USD) by net assets (€55.32 Million ≈ $64.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ONWD days of operational coverage to measure how many days the company can operate on defensive assets alone.

Onward Medical N.V. - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Acrow Ltd AU:ACF	0.085x
Steyr Motors AG VI:4X0	N/A
RCI Hospitality Holdings Inc NASDAQ:RICK	0.051x
eGain Corporation NASDAQ:EGAN	-0.020x
GENFIT S.A. ADR/1 EO-25 F:XUPB	N/A
Asia Electronic Material Co Ltd TWO:4939	0.055x
D2L Inc TO:DTOL	0.151x
Solvar Ltd AU:SVR	0.099x

Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2025)

The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Onward Medical N.V. (ONWD) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€55.32 Million ≈ $64.67 Million	€-39.07 Million ≈ $-45.67 Million	-0.706x	-6.85%
2024-12-31	€48.05 Million ≈ $56.18 Million	€-31.76 Million ≈ $-37.13 Million	-0.661x	+63.27%
2023-12-31	€17.93 Million ≈ $20.96 Million	€-32.27 Million ≈ $-37.73 Million	-1.800x	-254.95%
2022-12-31	€52.63 Million ≈ $61.53 Million	€-26.68 Million ≈ $-31.20 Million	-0.507x	-110.94%
2021-12-31	€82.68 Million ≈ $96.67 Million	€-19.87 Million ≈ $-23.23 Million	-0.240x	-159.80%
2020-12-31	€-32.09 Million ≈ $-37.52 Million	€-12.90 Million ≈ $-15.08 Million	0.402x	-39.07%
2019-12-31	€-14.92 Million ≈ $-17.45 Million	€-9.85 Million ≈ $-11.51 Million	0.660x	-5.33%
2018-12-31	€-10.27 Million ≈ $-12.01 Million	€-7.16 Million ≈ $-8.37 Million	0.697x	--

About Onward Medical N.V.

BR:ONWD Belgium Biotechnology

Market Cap

$217.03 Million

€185.64 Million EUR

Market Cap Rank

#16633 Global

#71 in Belgium

Share Price

€2.67

Change (1 day)

+1.52%

52-Week Range

€2.51 - €5.52

All Time High

€12.90